
Home » FDA Allows Marketing of Device for Carbon Monoxide Treatment
FDA Allows Marketing of Device for Carbon Monoxide Treatment

March 15, 2019
The FDA has given the green light for Thornhill Medical’s ClearMate, a device for use in emergency rooms for treating patients with carbon monoxide poisoning.
The mask device — which is made up of valves, meters, breathing circuits, a gas mixer and an oxygen reservoir — can quickly remove carbon monoxide from the body by increasing the patient’s rate of breathing.
ClearMate provides pure oxygen to the patient and a mixture of carbon dioxide and oxygen, making the patient breathe faster to speed up the rate of carbon dioxide exiting the body.
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr